Utilizza questo identificativo per citare o creare un link a questo documento: http://elea.unisa.it/xmlui/handle/10556/1647

Autore:	Capasso, Letizia Borrelli, Angela Carla Cerullo, Julia Pisanti, R. Figliuolo, C. Izzo, Federica Paccone, M. Ferrara, Teresa Lama, Silvia Raimondi, Francesco
Abstract:	Neonates, especially VLBW, are at high risk for sepsis related morbidity and mortality for immaturity of their immune system and invasive NICU practices. The paucity of immunoglobulins in preterm neonates consequently to the immaturity of immune system contributes to their high risk for systemic infection. The use of intravenous IgM enriched immunoglobulins, with higher antimicrobial activity than standard IgG, has been demonstrated in a retrospective study to reduce short term mortality in VLBW infant with proven sepsis. Larger, randomized prospective trials given the enormous burden of morbidity and mortality imposed by neonatal sepsis should urgently be addressed not only to validate this results but also to tailor the optimal scheme of treatment.
È visualizzato nelle collezioni:	Translational Medicine @ UniSa. Volume 11 (jan.-apr. 2015)

File in questo documento:

Non ci sono file allegati a questo documento

DSpace JSPUI